PRLAX | SLARX | PRLAX / SLARX | |
Total Expense Ratio | 1.46 | 1.18 | 124% |
Annual Report Gross Expense Ratio | 1.46 | 1.33 | 110% |
Fund Existence | 31 years | 10 years | - |
Gain YTD | 22.243 | 28.354 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 365M | 275M | 133% |
Annual Yield % from dividends | 2.93 | 4.21 | 69% |
Returns for 1 year | -0.45 | 3.79 | -12% |
Returns for 3 years | 12.38 | 15.31 | 81% |
Returns for 5 years | 37.48 | 66.59 | 56% |
Returns for 10 years | 12.92 | 86.78 | 15% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LCRIX | 22.09 | 0.06 | +0.27% |
Leuthold Core Investment Institutional | |||
AFGFX | 77.27 | -0.05 | -0.06% |
Virtus Silvant Focused Growth R6 | |||
CLWFX | 75.50 | -0.07 | -0.09% |
Columbia Large Cap Growth Inst2 | |||
MXCAX | 11.35 | -0.09 | -0.79% |
BlackRock Emerging Markets Ex-Chn Inv A | |||
NMMEX | 15.99 | -0.17 | -1.05% |
Northern Active M Emerging Market Equity |